Expert: Professor Tomasz Stokłosa Head, Department of Tumor Biology and Genetics / Laboratory of Molecular Genetics and Cytogenetics, University Clinical Center Medical University of Warsaw (Poland)

Program:
Overview of significant biological aspects presented during the meeting, including:

• Modeling stem cell dynamics in chronic myeloid leukemia (Richard van Etten) [04:18]
• Insights from single-cell analysis of CML stem cells (Göran Karlsson) [09:24]
• Early response prediction by single cell immune and signaling profiling in CML (Stein-Erik Gullaksen) [11:35]
• Impact of mitochondrial DNA mutations on metabolic adaptation and TKI response in CML (Ilaria Pagani) [14:00]
• Integrating genomic and transcriptomic factors for predicting responses and outcomes in CML on 3G-TKI therapy (Xiaoshuai Zhang) [15:42]
• SETD2 deficiency in CML induces metabolic reprogramming contributing to drug resistance and disease progression (Manuela Mancini) [16:24]
• Comprehensive molecular characterisation of treatment-free remission in CML patients - The EURO-SKI Biomarker Study (Sebastien Rinaldetti)[16:59]
  
  

Q&A Session can be found at the end of the clinical overview.

If you have any questions or comments to the speaker, please email info@cml-foundation.org.